Taxotere (generic: docetaxel) is primarily used to treat breast cancer; however, it may also be prescribed for the treatment of non-small cell lung cancer, prostate cancer, stomach (gastric) cancer and head/neck cancer. The drug works by interfering with the growth and spread of cancer cells in the body. In February 2012, a study published in the Annals of Oncology found that Taxotere is associated with an increased risk of permanent alopecia. The study involved 20 female breast cancer patients who were treated with docetaxel and subsequently developed permanent hair loss. Researchers ruled out mineral deficiencies and thyroid disorders as contributing factors, and noted that all but one of the women had no history of alopecia. If you or a loved one suffered from permanent hair loss after using the chemotherapy drug Taxotere, call The Goss Law Firm, P.C. for a free consultation.